Improving the Process of Therapeutic Development
Harvard, MIT, and the FDA have partnered to create a center focused on regulatory science, bringing together a range of scientific disciplines that are applied to assess the quality, safety and efficacy of medicinal products and inform regulatory decision-making throughout the lifecycle of a medicine. Working across academia, industry, and government institutions, the Center promotes regulatory science through research and education programs, uniting stakeholders under a common mission: promoting optimal patient health outcomes through biomedical innovation and the availability of safe and effective diagnostics and treatments.
Featured Publications
The Regulatory Science Fellowship Program
Our fellowship program is affiliated with the FDA and focuses on training the next generation of regulatory science researchers. Learn more about the research our fellows are conducting or explore opportunities and how to get involved in our program.
News, Events, & Updates
Regulatory Science Forum: Fellows Showcase, Jan 24
12pm-1:30pm, Harvard Medical School, Armenise 108
Twitter @Harvardmit_CRS
Happy #FollowFriday! Today we spotlight another
@HarvardMIT_CRS @HiTSatHarvard fellow, @DrSinhaEsq!
Dr. Sinha completed MD & JD degrees from @SIUSOM @SIUSchoolofLaw, an MPH from @HarvardChanSPH and works with @akesselheim at @PORTAL_Research
#RegSci2020 https://scholar.harvard.edu/sinha
Finally put this new manuscript on arXiv! "A general Bayesian bootstrap for censored data based on the beta-Stacy process". Joint work with Pietro Muliere.
https://arxiv.org/abs/2002.04081
Happy #InternationalDayOfWomenInScience from us at HiTS @harvard. Today we are celebrating the brilliant #WomenInScience who are leading innovation and scientific discoveries!
#WomenInSTEM
Wai Cheung (Adrian) Chan, student in Chemical Biology PhD Program saves the day for @Frank_S_David with a more biology-oriented talk on DUBs and the development of a chemoproteomic platform that could lead to discovery of new DUB inhibitors and novel therapeutic opportunities!
@GopalKot PhD student at T.H. Chan Harvard School of Public Health is discussing factorial clinical trial designs and potential applications @LorenzoTrippa